Education
About Us
Working with TipRanks
Follow Us
Ronald W. McClurg Insider Profile
4 Followers
Ronald W. McClurg, CFO at NeuroOne Medical Technologies, holds 244.12K shares in NeuroOne Medical Technologies (Ticker: NMTC), holds ― shares in Healthcare Triangle (Ticker: HCTI).
Ronald W. McClurg NeuroOne Medical Technologies (NMTC)CFO
NeuroOne Medical Technologies (NMTC)
CFO
Ranked #32,481 out of 100,956 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+7.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ronald W. McClurg holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 14, 2022 - Jun 14, 2023
Return:+27.30%
The most profitable trade made by Ronald W. McClurg
Ronald W. McClurg's Trading History
NeuroOne Medical Technologies
Feb 21, 2024
CFO
Uninformative Buy
―
$240.46K
Healthcare Triangle
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Ronald W. McClurg's performance on stock
You May Also Like
Ronald W. McClurg insider profile FAQ
What is the percentage of profitable transactions made by Ronald W. McClurg?
The percentage of profitable transactions made by Ronald W. McClurg is 75%.
What is the average return per transaction made by Ronald W. McClurg?
The average return per transaction made by Ronald W. McClurg is 7.30%.
What stocks does Ronald W. McClurg hold?
Ronald W. McClurg holds: NMTC, HCTI stocks.
What was Ronald W. McClurg’s latest transaction?
Ronald W. McClurg latest transaction was an Uninformative Buy of ―.
What was Ronald W. McClurg's most profitable transaction?
Ronald W. McClurg’s most profitable transaction was an Informative Buy of NMTC stock on June 14, 2022. The return on the trade was 27.30%.
What is Ronald W. McClurg's role in NeuroOne Medical Technologies?
Ronald W. McClurg's role in NeuroOne Medical Technologies is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.